Find Research Outputs

Search results

• 2018

  Amide proton transfer imaging can predict tumor grade in rectal cancer

  Nishie, A., Takayama, Y., Asayama, Y., Ishigami, K., Ushijima, Y., Okamoto, D., Fujita, N., Tsurumaru, D., Togao, O., Manabe, T., Oki, E., Kubo, Y., Hida, T., Hirahashi-Fujiwara, M., Keupp, J. & Honda, H., Sep 2018, In: Magnetic Resonance Imaging. 51, p. 96-103 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Proton transfer
  • Amides
  • Tumors
  • Rectal Neoplasms
  • Protons
  12 Citations (Scopus)

• A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study

  Oki, E., Kato, T., Bando, H., Yoshino, T., Muro, K., Taniguchi, H., Kagawa, Y., Yamazaki, K., Yamaguchi, T., Tsuji, A., Iwamoto, S., Nakayama, G., Emi, Y., Touyama, T., Nakamura, M., Kotaka, M., Sakisaka, H., Yamanaka, T. & Kanazawa, A., Jun 2018, In: Clinical Colorectal Cancer. 17, 2, p. 147-155 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Oxaliplatin
  • Irinotecan
  • Bevacizumab
  • Fluorouracil
  • Colorectal Neoplasms
  19 Citations (Scopus)

• A multicentre, prospective clinical evaluation study for analyzing RAS mutational status utilizing plasma circulating tumor DNA in patients with metastatic colorectal cancer

  Kagawa, Y., Kato, T., Bando, H., Akagi, K., Denda, T., Nishina, T., Komatsu, Y., Oki, E., Kudo, T., Yamanaka, T. & Yoshino, T., Jun 1 2018, In: Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. v101-v102

  Research output: Contribution to journal › Article › peer-review

  Open Access
  14 Citations (Scopus)

• A novel histological examination with dynamic three-dimensional reconstruction from multiple immunohistochemically stained sections of a PD-L1-positive colon cancer

  Korehisa, S., Ikeda, T., Okano, S., Saeki, H., Oki, E., Oda, Y., Hashizume, M. & Maehara, Y., Mar 2018, In: Histopathology. 72, 4, p. 697-703 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Colonic Neoplasms
  • Cell Death
  • Ligands
  • Microsatellite Instability
  • Lymphatic Endothelium
  4 Citations (Scopus)

• A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC) refractory to standard chemotherapy: APOLLON study

  Yamazaki, K., Yasui, H., Yamaguchi, K., Kagawa, Y., Kuboki, Y., Yoshino, T., Gamoh, M., Komatsu, Y., Satake, H., Goto, M., Tanioka, H., Oki, E., Kotaka, M., Makiyama, A., Denda, T., Soeda, J., Shibya, K., Iwata, M., Oba, K. & Kato, T., Jun 1 2018, In: Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. v71

  Research output: Contribution to journal › Article › peer-review

  Open Access
  82 Citations (Scopus)

• A phase II study of nab-paclitaxel in combination with ramucirumab in patients with previously treated advanced gastric cancer

  Bando, H., Shimodaira, H., Fujitani, K., Takashima, A., Yamaguchi, K., Nakayama, N., Takahashi, T., Oki, E., Azuma, M., Nishina, T., Hironaka, S., Komatsu, Y. & Shitara, K., Mar 2018, In: European Journal of Cancer. 91, p. 86-91 6 p.

  Research output: Contribution to journal › Article › peer-review

  • ramucirumab
  • Albumin-Bound Paclitaxel
  • Nanoparticles
  • Stomach Neoplasms
  • Advisory Committees
  22 Citations (Scopus)

• A phase II study of nab-PTX in combination with RAM in patients with pre-treated AGC: results of final analysis

  Takashima, A., Bando, H., Shimodaira, H., Fujitani, K., Yamaguchi, K., Nakayama, N., Takahashi, T., Oki, E., Azuma, M., Nishina, T., Hironaka, S., Komatsu, Y. & Shitara, K., Oct 1 2018, In: Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. vii67

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Assessment of Sarcopenia as a Predictor of Poor Outcomes after Esophagectomy in Elderly Patients with Esophageal Cancer

  Nakashima, Y., Saeki, H., Nakanishi, R., Sugiyama, M., Kurashige, J., Oki, E. & Maehara, Y., Jun 1 2018, In: Annals of surgery. 267, 6, p. 1100-1104 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Sarcopenia
  • Esophagectomy
  • Esophageal Neoplasms
  • Elderly
  • Anastomotic Leak
  63 Citations (Scopus)

• BUBR1 insufficiency is correlated with eNOS reduction experimentally in vitro and in vivo, and in gastric cancer tissue

  Kawakubo, E., Matsumoto, T., Yoshiya, K., Yamashita, S., Jogo, T., Saeki, H., Oki, E., Furuyama, T., Oda, Y. & Maehara, Y., Nov 2018, In: Anticancer research. 38, 11, p. 6099-6106 8 p.

  Research output: Contribution to journal › Article › peer-review

  • benzimidazole
  • Nitric Oxide Synthase Type III
  • Stomach Neoplasms
  • In Vitro Techniques
  • Human Umbilical Vein Endothelial Cells
  2 Citations (Scopus)

• Capecitabine reverses tumor escape from anti-VEGF through the eliminating CD11bhigh/Gr1high myeloid cells

  Iwai, T., Harada, Y., Saeki, H., Oki, E., Maehara, Y. & Yonemitsu, Y., Apr 3 2018, In: Oncotarget. 9, 25, p. 17620-17630 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Tumor Escape
  • Capecitabine
  • Myeloid Cells
  • Vascular Endothelial Growth Factor A
  • Myeloid-Derived Suppressor Cells

• Capecitabine reverses tumor escape from anti-VEGF through the eliminating CD11b^high/Gr1^high myeloid cells

  Iwai, T., Harada, Y., Saeki, H., Oki, E., Maehara, Y. & Yonemitsu, Y., Apr 1 2018, In: Oncotarget. 9, 25, p. 17620-17630 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Tumor Escape
  • Capecitabine
  • Myeloid Cells
  • Vascular Endothelial Growth Factor A
  • Myeloid-Derived Suppressor Cells
  4 Citations (Scopus)

• CD44v9 is associated with epithelial-mesenchymal transition and poor outcomes in esophageal squamous cell carcinoma

  Taniguchi, D., Saeki, H., Nakashima, Y., Kudou, K., Nakanishi, R., Kubo, N., Ando, K., Oki, E., Oda, Y. & Maehara, Y., Dec 2018, In: Cancer Medicine. 7, 12, p. 6258-6268 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Esophageal Squamous Cell Carcinoma
  • Epithelial-Mesenchymal Transition
  • Neoplasms
  • Neoplastic Stem Cells
  • Survival
  5 Citations (Scopus)

• Changes in HER2 expression and amplification status following preoperative chemotherapy for gastric cancer

  Shu, S., Iimori, M., Nakanishi, R., Jogo, T., Saeki, H., Oki, E. & Maehara, Y., Nov 1 2018, In: In Vivo. 32, 6, p. 1491-1498 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Chemotherapy
  • human ERBB2 protein
  • Amplification
  • Stomach Neoplasms
  • Drug Therapy
  3 Citations (Scopus)

• Clinical and Genetic Implications of Mutation Burden in Squamous Cell Carcinoma of the Lung

  Okamoto, T., Takada, K., Sato, S., Toyokawa, G., Tagawa, T., Shoji, F., Nakanishi, R., Oki, E., Koike, T., Nagahashi, M., Ichikawa, H., Shimada, Y., Watanabe, S., Kikuchi, T., Akazawa, K., Lyle, S., Takabe, K., Okuda, S., Sugio, K., Wakai, T. & 2 others, Tsuchida, M. & Maehara, Y., Jun 1 2018, In: Annals of Surgical Oncology. 25, 6, p. 1564-1571 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Squamous Cell Carcinoma
  • Mutation
  • Lung
  • Neoplasms
  • Cyclin-Dependent Kinase Inhibitor p15
  9 Citations (Scopus)

• Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability

  Korehisa, S., Oki, E., Iimori, M., Nakaji, Y., Shimokawa, M., Saeki, H., Okano, S., Oda, Y. & Maehara, Y., Feb 15 2018, In: International Journal of Cancer. 142, 4, p. 822-832 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Microsatellite Instability
  • Colorectal Neoplasms
  • Cell Death
  • Ligands
  • B7-H1 Antigen
  25 Citations (Scopus)

• Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer

  Inoue, Y., Yamashita, N., Kitao, H., Tanaka, K., Saeki, H., Oki, E., Oda, Y., Tokunaga, E. & Maehara, Y., Aug 2018, In: Clinical Breast Cancer. 18, 4, p. e643-e650

  Research output: Contribution to journal › Article › peer-review

  • Protein Phosphatase 1
  • Phosphoric Monoester Hydrolases
  • Magnesium
  • Phosphoprotein Phosphatases
  • Breast Neoplasms
  3 Citations (Scopus)

• Clinicopathologic and molecular characteristics of synchronous colorectal carcinoma with mismatch repair deficiency

  Nakano, K., Yamamoto, H., Fujiwara, M., Koga, Y., Tsuruta, S., Ihara, E., Oki, E., Nakamura, M., Ogawa, Y. & Oda, Y., 2018, In: American Journal of Surgical Pathology. 42, 2, p. 172-182 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Turcot syndrome
  • DNA Mismatch Repair
  • Colorectal Neoplasms
  • Hereditary Nonpolyposis Colorectal Neoplasms
  • Neoplasms
  8 Citations (Scopus)

• Correction to: S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102) (International Journal of Clinical Oncology, (2016), 21, 4, (705-712), 10.1007/s10147-015-0943-z)

  Miyamoto, Y., Tsuji, A., Tanioka, H., Maekawa, S., Kawanaka, H., Kitazono, M., Oki, E., Emi, Y., Murakami, H., Ogata, Y., Saeki, H., Shimokawa, M., Natsugoe, S., Akagi, Y., Baba, H. & Maehara, Y., Apr 1 2018, In: International Journal of Clinical Oncology. 23, 2, p. 402 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  • Medical Oncology
  • Oxaliplatin
  • Irinotecan
  • Bevacizumab
  • Japan

• Developing a Phosphospecific IHC Assay as a Predictive Biomarker for Topoisomerase I Inhibitors

  Ando, K., Tohme, Y. H., Srinivasiah, A., Taylor-Parker, J., Harrington, Y., Shah, A. K., Oki, E., Brahmandam, M. & Bharti, A. K., Aug 1 2018, In: Journal of Histochemistry and Cytochemistry. 66, 8, p. 549-561 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Topoisomerase I Inhibitors
  • Type I DNA Topoisomerase
  • Phosphotransferases
  • Biomarkers
  • Phosphoric Monoester Hydrolases

• Differences in PD-L1 expression on tumor and immune cells between lung metastases and corresponding primary tumors

  Takamori, S., Takada, K., Tagawa, T., Toyokawa, G., Hirai, F., Yamashita, N., Okamoto, T., Oki, E., Yoshizumi, T., Oda, Y. & Maehara, Y., Dec 2018, In: Surgical Oncology. 27, 4, p. 637-641 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Cell Death
  • Ligands
  • Neoplasm Metastasis
  • Lung
  • Neoplasms
  5 Citations (Scopus)

• DNA replication stress and cancer chemotherapy

  Kitao, H., Iimori, M., Kataoka, Y., Wakasa, T., Tokunaga, E., Saeki, H., Oki, E. & Maehara, Y., Feb 1 2018, In: Cancer Science. 109, 2, p. 264-271 8 p.

  Research output: Contribution to journal › Review article › peer-review

  • DNA Replication
  • Drug Therapy
  • Neoplasms
  • Genomic Instability
  • Biological Phenomena
  23 Citations (Scopus)

• Effect of age factors on health-related quality of life in patients with lower rectal cancer after sphincter-saving surgery: A 1-year longitudinal study

  Kinoshita, Y., Izukura, R., Miyazono, M., Nagai, S., Oki, E., Kanaoka, M., Nakao, H., Chishaki, A. & Mibu, R., Nov 1 2018, In: Archives of Gerontology and Geriatrics. 79, p. 185-191 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Age Factors
  • surgery
  • Rectal Neoplasms
  • cancer
  • Longitudinal Studies

• Effect of early oral feeding on length of hospital stay following gastrectomy for gastric cancer: a Japanese multicenter, randomized controlled trial

  Shimizu, N., Oki, E., Tanizawa, Y., Suzuki, Y., Aikou, S., Kunisaki, C., Tsuchiya, T., Fukushima, R., Doki, Y., Natsugoe, S., Nishida, Y., Morita, M., Hirabayashi, N., Hatao, F., Takahashi, I., Choda, Y., Iwasaki, Y. & Seto, Y., Sep 1 2018, In: Surgery today. 48, 9, p. 865-874 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Gastrectomy
  • Stomach Neoplasms
  • Length of Stay
  • Randomized Controlled Trials
  • Postoperative Complications
  12 Citations (Scopus)

• Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer

  Yamashita, N., Tokunaga, E., Iimori, M., Inoue, Y., Tanaka, K., Kitao, H., Saeki, H., Oki, E. & Maehara, Y., Oct 2018, In: Clinical Breast Cancer. 18, 5, p. e1003-e1009

  Research output: Contribution to journal › Article › peer-review

  • Vimentin
  • Cadherins
  • Breast Neoplasms
  • Neoplasm Metastasis
  • Neoplasms
  24 Citations (Scopus)

• Erratum to: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition (Nature Medicine, (2018), 24, 7, (968-977), 10.1038/s41591-018-0022-x)

  Wong, G. S., Zhou, J., Bin Liu, J., Wu, Z., Xu, X., Li, T., Xu, D., Schumacher, S. E., Puschhof, J., McFarland, J., Zou, C., Dulak, A., Henderson, L., Xu, P., O’Day, E., Rendak, R., Liao, W. L., Cecchi, F., Hembrough, T., Schwartz, S. & 18 others, Szeto, C., Rustgi, A. K., Wong, K. K., Diehl, J. A., Jensen, K., Graziano, F., Ruzzo, A., Fereshetian, S., Mertins, P., Carr, S. A., Beroukhim, R., Nakamura, K., Oki, E., Watanabe, M., Baba, H., Imamura, Y., Catenacci, D. & Bass, A. J., Oct 1 2018, In: Nature medicine. 24, 10, p. 1627 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  • Mitogen-Activated Protein Kinase Kinases
  • Medicine
  • Actins
  • Neoplasms
  1 Citation (Scopus)

• Gastric cancer of "Crawling type" detected by additional gastrectomy after endoscopic submucosal resection

  Haruta, Y., Nakanishi, R., Jogo, T., Nakashima, Y., Saeki, H., Eiji, O. K. I., Fujiwara, M., Yoshinao, O. D. A. & Maehara, Y., Apr 2018, In: Anticancer research. 38, 4, p. 2335-2338 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Gastrectomy
  • Stomach Neoplasms
  • Stomach
  • Gastroscopy
  • Biopsy
  1 Citation (Scopus)

• Gastric cancer with synchronous and metachronous hepatic metastasis predicted by enhancement pattern on multiphasic contrast-enhanced CT

  Tsurumaru, D., Nishimuta, Y., Muraki, T., Asayama, Y., Nishie, A., Oki, E. & Honda, H., Nov 2018, In: European Journal of Radiology. 108, p. 165-171 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Stomach Neoplasms
  • Neoplasm Metastasis
  • Liver
  • Recurrence
  • Gastroscopy
  1 Citation (Scopus)

• Histopathologic evaluation of patients with liver-limited metastatic colorectal cancer receiving mFOLFOX6 plus bevacizumab or mFOLFOX6 plus cetuximab: The ATOM trial

  Emi, Y., Yamanaka, T., Muro, K., Uetake, H., Oki, E., Takahashi, T., Katayose, Y., Yoshida, K., Sakamoto, M., Aishima, S., Ishida, K., Imura, J., Unno, M., Hyodo, I., Tomita, N., Sugihara, K. & Maehara, Y., Oct 1 2018, In: Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii164

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer

  Hu, Q., Masuda, T., Sato, K., Tobo, T., Nambara, S., Kidogami, S., Hayashi, N., Kuroda, Y., Ito, S., Eguchi, H., Saeki, H., Oki, E., Maehara, Y. & Mimori, K., Mar 1 2018, In: Annals of Surgical Oncology. 25, 3, p. 745-753 9 p.

  Research output: Contribution to journal › Article › peer-review

  • ADP-Ribosylation Factors
  • Stomach Neoplasms
  • Datasets
  • Singapore
  • Genes
  15 Citations (Scopus)

• Impact of Concurrent Genomic Alterations Detected by Comprehensive Genomic Sequencing on Clinical Outcomes in East-Asian Patients with EGFR-Mutated Lung Adenocarcinoma

  Sato, S., Nagahashi, M., Koike, T., Ichikawa, H., Shimada, Y., Watanabe, S., Kikuchi, T., Takada, K., Nakanishi, R., Oki, E., Okamoto, T., Akazawa, K., Lyle, S., Ling, Y., Takabe, K., Okuda, S., Wakai, T. & Tsuchida, M., Dec 1 2018, In: Scientific reports. 8, 1, 1005.

  Research output: Contribution to journal › Article › peer-review

  • Adenocarcinoma of Lung
  • Atlases
  • Mutation
  • Genome
  • Neoplasm Genes
  11 Citations (Scopus)

• Initial report of a phase I/II study of S-1 and irinotecan (IRIS) in combination with cetuximab in patients with wild-type RAS metastatic colorectal cancer

  Oki, E., Samura, H., Okumura, H., Ohchi, T., Orita, H., Kobayashi, K., Kinjo, T., Mori, S., Touyama, T., Ohgaki, K., Kawanaka, H., Makiyama, A., Ureshino, N., Kotaka, M., Shimose, T., Saeki, H., Nishimaki, T., Baba, H. & Maehara, Y., Oct 1 2018, In: Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii166

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Laparoscopic Proximal Gastrectomy Maintains Body Weight and Skeletal Muscle Better Than Total Gastrectomy

  Sugiyama, M., Oki, E., Ando, K., Nakashima, Y., Saeki, H. & Maehara, Y., Oct 1 2018, In: World journal of surgery. 42, 10, p. 3270-3276 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Gastrectomy
  • Skeletal Muscle
  • Body Weight
  • Stomach Neoplasms
  • Weight Loss
  13 Citations (Scopus)

• Low visceral fat content is a negative predictive marker for bevacizumab in metastatic colorectal cancer

  Miyamoto, Y., Oki, E., Emi, Y., Tokunaga, S., Shimokawa, M., Ogata, Y., Akagi, Y., Sakamoto, Y., Tanaka, T., Saeki, H., Maehara, Y. & Baba, H., Jan 2018, In: Anticancer research. 38, 1, p. 491-499 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Intra-Abdominal Fat
  • Bevacizumab
  • Colorectal Neoplasms
  • Survival
  • Confidence Intervals
  3 Citations (Scopus)

• Multicenter phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) - Trial in progress

  Kato, T., Satake, H., Oba, K., Kagawa, Y., Yasui, H., Nakamura, M., Watanabe, T., Matsumoto, T., Hirata, K., Muro, K., Komatsu, Y., Yoshino, T., Yamazaki, K., Mishima, H., Kotaka, M., Tsuji, A., Kakeji, Y., Oki, E., Nagata, N. & Sakamoto, J., Jun 1 2018, In: Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. v83

  Research output: Contribution to journal › Article › peer-review

  Open Access
  15 Citations (Scopus)

• Neoadjuvant Chemoradiotherapy for Patients with cT3/Nearly T4 Esophageal Cancer: Is Sarcopenia Correlated with Postoperative Complications and Prognosis?

  Saeki, H., Nakashima, Y., Kudou, K., Sasaki, S., Jogo, T., Hirose, K., Edahiro, K., Korehisa, S., Taniguchi, D., Nakanishi, R., Kubo, N., Ando, K., Kabashima, A., Oki, E. & Maehara, Y., Sep 1 2018, In: World journal of surgery. 42, 9, p. 2894-2901 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Sarcopenia
  • Chemoradiotherapy
  • Esophageal Neoplasms
  • Postoperative Complications
  • Esophageal Squamous Cell Carcinoma
  10 Citations (Scopus)

• Neoadjuvant chemotherapy versus chemoradiotherapy for patients with esophageal squamous cell carcinoma

  Nakashima, Y., Saeki, H., Hu, Q., Tsuda, Y., Hisamatsu, Y., Ando, K., Oki, E. & Maehara, Y., Dec 2018, In: Anticancer research. 38, 12, p. 6809-6814 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Esophageal Squamous Cell Carcinoma
  • Chemoradiotherapy
  • Drug Therapy
  • Esophageal Neoplasms
  • Survival
  2 Citations (Scopus)

• Phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results

  Kagawa, Y., Satake, H., Kato, T., Oba, K., Yasui, H., Nakamura, M., Watanabe, T., Hirata, K., Muro, K., Komatsu, Y., Yoshino, T., Yamazaki, K., Mishima, H., Kotaka, M., Tsuji, A., Kakeji, Y., Oki, E., Nagata, N. & Junichi, S., Nov 1 2018, In: Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. ix34-ix35

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Phase II study of S-1 and oxaliplatin as neo-adjuvant chemotherapy for locally advanced gastric and esophago-gastric cancer (KSCC1601)

  Kobayashi, K., Iwatsuki, M., Orita, H., Hidaka, S., Arigami, T., Kusumoto, T., Satake, H., Oki, E., Satoshi, K., Tobimatsu, K., Shimokawa, M., Saeki, H., Makiyama, A., Kakeji, Y., Natsugoe, S., Baba, H., Eguchi, S. & Maehara, Y., Oct 1 2018, In: Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii225-viii226

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Prophylactic Effect of Dexamethasone on Regorafenib-Related Fatigue and/or Malaise: A Randomized, Placebo-Controlled, Double-Blind Clinical Study in Patients with Unresectable Metastatic Colorectal Cancer (KSCC1402/HGCSG1402)

  Tanioka, H., Miyamoto, Y., Tsuji, A., Asayama, M., Shiraishi, T., Yuki, S., Kotaka, M., Makiyama, A., Shimokawa, M., Shimose, T., Masuda, S., Yamaguchi, T., Komatsu, Y., Saeki, H., Emi, Y., Baba, H., Oki, E. & Maehara, Y., Apr 1 2018, In: Oncology (Switzerland). 94, 5, p. 289-296 8 p.

  Research output: Contribution to journal › Article › peer-review

  • regorafenib
  • Double-Blind Method
  • Dexamethasone
  • Fatigue
  • Colorectal Neoplasms
  3 Citations (Scopus)

• Rationale and design of the TRUSTY study: a randomised, multicentre, open-label phase II/III study of trifluridine/tipiracil plus bevacizumab versus irinotecan, fluoropyrimidine plus bevacizumab as second-line treatment in patients with metastatic colorectal cancer progressive during or following first-line oxaliplatin-based chemotherapy

  Yoshino, T., Oki, E., Nozawa, H., Eguchi-Nakajima, T., Taniguchi, H., Morita, S., Takenaka, N., Ozawa, D. & Shirao, K., 2018, In: ESMO Open. 3, 5, p. e000411

  Research output: Contribution to journal › Article › peer-review

  • trifluridine tipiracil
  • Oxaliplatin
  • Irinotecan
  • Bevacizumab
  • Colorectal Neoplasms

• Rationale and design of the TRUSTY study: A randomised, multicentre, open-label phase II/III study of trifluridine/tipiracil plus bevacizumab versus irinotecan, fluoropyrimidine plus bevacizumab as second-line treatment in patients with metastatic colorectal cancer progressive during or following first-line oxaliplatin-based chemotherapy

  Yoshino, T., Oki, E., Nozawa, H., Eguchi-Nakajima, T., Taniguchi, H., Morita, S., Takenaka, N., Ozawa, D. & Shirao, K., Aug 1 2018, In: ESMO Open. 3, 5, e000411.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • trifluridine tipiracil
  • Oxaliplatin
  • Irinotecan
  • Bevacizumab
  • Colorectal Neoplasms
  5 Citations (Scopus)

• Recent advances in treatment for colorectal liver metastasis

  Oki, E., Ando, K., Nakanishi, R., Sugiyama, M., Nakashima, Y., Kubo, N., Kudou, K., Saeki, H., Nozoe, T., Emi, Y. & Maehara, Y., May 2018, In: Annals of Gastroenterological Surgery. 2, 3, p. 167-175 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Neoplasm Metastasis
  • Colorectal Neoplasms
  • Drug Therapy
  • Liver
  • ErbB Receptors

• Recent incidence trend of surgically resected esophagogastric junction adenocarcinoma and microsatellite instability status in Japanese patients

  Imamura, Y., Watanabe, M., Toihata, T., Takamatsu, M., Kawachi, H., Haraguchi, I., Ogata, Y., Yoshida, N., Saeki, H., Oki, E., Taguchi, K., Yamamoto, M., Morita, M., Mine, S., Hiki, N., Baba, H. & Sano, T., Dec 1 2018, In: Digestion. 99, 1, p. 6-13 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Esophagogastric Junction
  • Microsatellite Instability
  • Adenocarcinoma
  • Incidence
  • Japan
  12 Citations (Scopus)

• Re-evaluation of HER2 status in patients with HER2-positive advanced or recurrent gastric cancer refractory to trastuzumab (KSCC1604)

  KYUSHU STUDY GROUP OF CLINICAL CANCER (KSCC), Dec 2018, In: European Journal of Cancer. 105, p. 41-49 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Trastuzumab
  • Stomach Neoplasms
  • Formaldehyde
  • Adenocarcinoma
  • Fixatives
  14 Citations (Scopus)

• Research of the cancer-odor

  Sonoda, H., Oki, E., Tanaka, M., Matsui, T., Onodera, T., Toko, K., Satoh, Y. & Maehara, Y., Jun 2018, In: Japanese Journal of Cancer and Chemotherapy. 45, 6, p. 911-915 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Odorants
  • Neoplasms
  • Smell
  • Happiness
  • Dreams

• REVERCE: Randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for metastatic colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, and irinotecan: Quality of life analysis

  Yoshino, T., Yamanaka, T., Denda, T., Tsuji, Y., Shinozaki, K., Komatsu, Y., Kobayashi, Y., Furuse, J., Okuda, H., Asayama, M., Akiyoshi, K., Kagawa, Y., Kato, T., Oki, E., Ando, T., Hagiwara, Y., Ohashi, Y. & Shitara, K., Jun 1 2018, In: Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. v95

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer

  Tsuchihashi, K., Ito, M., Moriwaki, T., Fukuoka, S., Taniguchi, H., Takashima, A., Kumekawa, Y., Kajiwara, T., Yamazaki, K., Esaki, T., Makiyama, A., Denda, T., Satake, H., Suto, T., Sugimoto, N., Katsumata, K., Ishikawa, T., Kashiwada, T., Oki, E., Komatsu, Y. & 8 others, Okuyama, H., Sakai, D., Ueno, H., Tamura, T., Yamashita, K., Kishimoto, J., Shimada, Y. & Baba, E., Dec 2018, In: Clinical Colorectal Cancer. 17, 4, p. e687-e697

  Research output: Contribution to journal › Article › peer-review

  • Colorectal Neoplasms
  • regorafenib
  • Drug Therapy
  • Progression-Free Survival
  • trifluridine tipiracil
  7 Citations (Scopus)

• Sarcopenia is an independent predictor of complications after colorectal cancer surgery

  Nakanishi, R., Oki, E., Sasaki, S., Hirose, K., Jogo, T., Edahiro, K., Korehisa, S., Taniguchi, D., Kudo, K., Kurashige, J., Sugiyama, M., Nakashima, Y., Ohgaki, K., Saeki, H. & Maehara, Y., Feb 1 2018, In: Surgery today. 48, 2, p. 151-157 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Sarcopenia
  • Colorectal Surgery
  • Colorectal Neoplasms
  • Postoperative Complications
  • Centers for Disease Control and Prevention (U.S.)
  34 Citations (Scopus)

• Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy

  Saeki, H., Emi, Y., Oki, E., Tokunaga, S., Kakeji, Y., Akagi, Y., Baba, H., Baba, E. & Maehara, Y., Jan 8 2018, In: BMC Cancer. 18, 1, 57.

  Research output: Contribution to journal › Article › peer-review

  • Phase II Clinical Trials
  • Oxaliplatin
  • Stomach Neoplasms
  • Drug Therapy
  • Japan
  1 Citation (Scopus)

• Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition letter

  Wong, G. S., Zhou, J., Liu, J. B., Wu, Z., Xu, X., Li, T., Xu, D., Schumacher, S. E., Puschhof, J., McFarland, J., Zou, C., Dulak, A., Henderson, L., Xu, P., O'Day, E., Rendak, R., Liao, W. L., Cecchi, F., Hembrough, T., Schwartz, S. & 18 others, Szeto, C., Rustgi, A. K., Wong, K. K., Diehl, J. A., Jensen, K., Graziano, F., Ruzzo, A., Fereshetian, S., Mertins, P., Carr, S. A., Beroukhim, R., Nakamura, K., Oki, E., Watanabe, M., Baba, H., Imamura, Y., Catenacci, D. & Bass, A. J., Jul 1 2018, In: Nature medicine. 24, 7, p. 968-977 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Mitogen-Activated Protein Kinase Kinases
  • Amplification
  • Chemical activation
  • Protein Tyrosine Phosphatases
  • Guanine
  65 Citations (Scopus)